Today's Top Health News Story

Ex-drug executive Shkreli congratulates Australian students

(Reuters) - Former pharmaceutical executive Martin Shkreli has congratulated a group of Australian students who reproduced the active ingredient for a life-saving, anti-parasitic drug at the center of a drug-price controversy involving his former company. Learn More


More Top Health Stories

New data on risk vs benefit for potent CAR-T cancer drugs

(Reuters) - A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. More »


U.S. pushes to close lead testing gaps, echoing Reuters report

NEW YORK (Reuters) - U.S. states must do more to ensure that all children enrolled in the Medicaid health care program are tested for lead poisoning, a U.S. Government agency said this week, acknowledging major gaps in screening that were highlighted in a recent Reuters investigation. More »


Germany detects H5N1 bird flu on poultry farm in Brandenburg

BERLIN (Reuters) - Germany reported a first case of the contagious bird flu strain H5N1 on Friday on a small poultry farm in the northeastern state of Brandenburg, the state's consumer protection ministry said. More »


Higher blood clot risk after starting testosterone treatment

(Reuters Health) - - Men may have an increased risk of blood clots after they start taking testosterone to treat sexual dysfunction, a recent study suggests. More »


Heavy teenage drinking linked to abnormal brain development

(Reuters Health) – - Teens who drink heavily are more likely than their peers to have less gray matter, an important brain structure that aids in memory, decisions, and self-control, according to a Finnish study. More »


Driving home from night shift may be safer with light therapy

(Reuters Health) - - Exhausted shift workers may be safer driving home at night when they're exposed to bright light before they hit the road, a small study suggests. More »


FDA lets Lilly cite Jardiance heart data, shares jump

(Reuters) - U.S regulators said on Friday they would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces risk of death from heart problems, lifting company shares almost 3 percent and potentially giving a strong boost to the drug's future sales. More »


U.S. health spending in 2015 rose at fastest rate since 2007

(Reuters) - U.S. health spending in 2015 rose at its fastest rate since 2007, driven by expanded access to insurance under the Affordable Care Act and high-priced specialty drugs, according to government figures released on Friday. More »


Amgen, Allergan apply for European nod for Avastin biosimilar

(Reuters) - Amgen Inc and Allergan Plc said they have submitted an application to the European health regulator seeking approval of their biosimilar version of Roche Holding AG's blockbuster cancer treatment, Avastin. More »


News, Photo and Web Search